maleimide has been researched along with Disease Models, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, ON; Jung, S; Lee, EK; Lee, SH; Thi Nguyen, NT | 1 |
Bublil, EM; Carrillo, RS; Kraus, JP; Majtan, T; Park, I | 1 |
Cabrales, P; Intaglietta, M; Tsai, AG; Winslow, RM; Young, MA | 1 |
Gao, J; Gao, Y; Li, C; Li, J; Li, Q; Liao, H; Mao, W; Pang, T; Xu, L; Xu, Y; Ye, Q; Zhang, L; Zhou, Y | 1 |
Anderson, ME; Burke, PJ; Doronina, SO; Hamilton, JZ; Hunter, JH; Jeffrey, SC; Lyon, RP; McKinney, EE; Miyamoto, JB; Okeley, NM; Senter, PD; Simmons, JK; Stone, IJ; Ulrich, ML | 1 |
Aljabali, AA; Dey, S; Evans, DJ; Lomonossoff, GP; Mealy, JE; Saxena, P; Shukla, S; Steinmetz, NF; Wen, AM; Yang, AC; Yildiz, I | 1 |
6 other study(ies) available for maleimide and Disease Models, Animal
Article | Year |
---|---|
Mono-PEGylates of exenatide in branched and dimeric structures can improve in vivo stability and hypoglycemic bioactivity.
Topics: Amino Acid Sequence; Animals; Blood Glucose; CHO Cells; Cricetulus; Cyclic AMP; Diabetes Mellitus, Type 2; Disease Models, Animal; Exenatide; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Maleimides; Mice; Mice, Nude; Mice, Obese; Molecular Weight; Polyethylene Glycols | 2019 |
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria.
Topics: Amino Acid Sequence; Animals; Cross-Linking Reagents; Cystathionine beta-Synthase; Cysteine; Delayed-Action Preparations; Disease Models, Animal; Enzyme Replacement Therapy; Homocysteine; Homocystinuria; Humans; Maleimides; Mice; Polyethylene Glycols; Succinimides | 2017 |
Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia.
Topics: Acute Disease; Anemia, Sickle Cell; Animals; Blood Substitutes; Capillaries; Cross-Linking Reagents; Disease Models, Animal; Female; Hemoglobins; Heterozygote; Hypoxia; Male; Maleimides; Mice; Mice, Transgenic; Microcirculation; Oxygen; Polyethylene Glycols | 2015 |
Synthesis and Evaluation of 3-(furo[2,3-b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3β Inhibitors and Anti-Ischemic Agents.
Topics: Animals; Brain Ischemia; Cells, Cultured; Chemistry Techniques, Synthetic; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Inhibitory Concentration 50; Maleimides; Molecular Docking Simulation; Neurons; Neuroprotective Agents; Rats; Structure-Activity Relationship | 2015 |
Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Stability; Humans; Immunoconjugates; Maleimides; Mice; Molecular Structure; Oligopeptides; Polyethylene Glycols; Survival Analysis; Xenograft Model Antitumor Assays | 2017 |
Interior engineering of a viral nanoparticle and its tumor homing properties.
Topics: Animals; Biocompatible Materials; Blotting, Western; Chromatography, Gel; Colonic Neoplasms; Comovirus; Disease Models, Animal; Drug Delivery Systems; Electrophoresis, Agar Gel; HeLa Cells; HT29 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Maleimides; Mice; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Particle Size | 2012 |